Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02434094 · ClinicalTrials.gov registry record

Development of a Comprehensive AP Training Curriculum for Adults

A clinical trial, sponsored by University of Virginia.

Completed
Registry status
24
Enrollment target

NCT02434094: Completed study, sponsored by University of Virginia.

NCT02434094 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02434094 has completed, sponsored by University of Virginia.

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

An e-learning training program is to prepare people with diabetes and their physicians on the use of UVA's Artificial Pancreas prototype -- Diabetes Assistant (DiAs).

Primary Outcome

Subjects learn how to properly operate \& configure DiAs.

Interventions

  • BEHAVIORAL eDAPT on-line training program

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2015-04
Est. Completion 2015-08
University of Virginia

449 total trials

What the finished NCT02434094 record still lists

NCT02434094 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which eDAPT on-line training program is the first listed.

NCT02434094 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02434094 about?

NCT02434094 is a clinical study titled "Development of a Comprehensive AP Training Curriculum for Adults". An e-learning training program is to prepare people with diabetes and their physicians on the use of UVA's Artificial Pancreas prototype -- Diabetes Assistant (DiAs).

What is the current status of trial NCT02434094?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2015-04. Estimated completion is 2015-08.

What interventions are being tested in trial NCT02434094?

The interventions under investigation include: eDAPT on-line training program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02434094?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02434094, the US trial registry maintained by the National Library of Medicine. NCT02434094 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.